South Korea & United States — National Institutes of Health

South Korea: South Korea is the home country of Sky Labs and where 'CART BP pro' is covered under the national health insurance system and recommended by national hypertension guidelines, serving as a key market for the company's validation and adoption.

United States — National Institutes of Health: The National Institutes of Health (NIH) under the United States — Centers for Disease Control and Prevention (KDCA) has adopted Sky Labs' platform for a large-scale cohort study, validating its utility as a data platform.

South Korea: South Korea is mentioned as the location of the Hantan River, after which the Hantavirus is named, due to a historical outbreak during the Korean War.

United States — National Institutes of Health: The United States — National Institutes of Health>>>'s decision to end funding for global infectious disease research networks has drawn criticism amid ongoing outbreaks.

South Korea: Included in study as a high-income country for comparison.

United States — National Institutes of Health: Provided grant funding, supporting high-impact global health research.

South Korea: South Korea is a country where Medicenna Therapeutics has pending patent applications, indicating its efforts to expand intellectual property protection globally.

United States — National Institutes of Health: The United States — National Institutes of Health is a co-owner of one of the newly issued US patents, indicating its collaboration with Medicenna Therapeutics on IL-4 Superkine fusion proteins.